Stephan Mueller, MA1,2; Ephraim B. Winzer, MD3; André Duvinage, MD1,2; Andreas B. Gevaert, MD, PhD4,5; Frank Edelmann, MD6,7; Bernhard Haller, Dr rer nat8; Elisabeth Pieske-Kraigher, MD6,7; Paul Beckers, PhD4,5; Anna Bobenko, MD6,7; Jennifer Hommel, MA3; Caroline M. Van de Heyning, MD, PhD4,5; Katrin Esefeld, MD1,2; Pia von Korn, MSc1,2; Jeffrey W. Christle, PhD1,9; Mark J. Haykowsky, PhD10; Axel Linke, MD3; Ulrik Wisl?ff, PhD11; Volker Adams, PhD3; Burkert Pieske, MD6,7; Emeline M. van Craenenbroeck, MD, PhD4,5; Martin Halle, MD1,2; for the OptimEx-Clin Study Group
doi : 10.1001/jama.2020.26812
JAMA. 2021;325(6):542-551
Endurance exercise is effective in improving peak oxygen consumption (peak V?o2) in patients with heart failure with preserved ejection fraction (HFpEF). However, it remains unknown whether differing modes of exercise have different effects.
Gregory Ducrocq, MD, PhD1; Jose R. Gonzalez-Juanatey, MD2; Etienne Puymirat, MD3; Gilles Lemesle, MD, PhD4,5; Marine Cachanado, MSc6; Isabelle Durand-Zaleski, MD, PhD7; Joan Albert Arnaiz, MD, PhD8,9; Manuel Mart?nez-Sellés, MD, PhD8,9; Johanne Silvain, MD, PhD10; Albert Ariza-Solé, MD11; Emile Ferrari, MD12; Gonzalo Calvo, MD, PhD13; Nicolas Danchin, MD3; Cristina Avenda?o-Sol?, MD14; Jerome Frenkiel, MD7; Alexandra Rousseau, PhD6; Eric Vicaut, MD, PhD15; Tabassome Simon, MD, PhD6,16; Philippe Gabriel Steg, MD1,17; for the REALITY Investigators
doi : 10.1001/jama.2021.0135
JAMA. 2021;325(6):552-560
The optimal transfusion strategy in patients with acute myocardial infarction and anemia is unclear.
Anne-Sophie Sillesen, MD, PhD1,2,3; Ottilia V?gg, MD2,3,4; Christian Pihl, MD2,3; Anna Axelsson Raja, MD, PhD1,2,3; Karin Sundberg, MD, DMSc3,5; Cathrine Vedel, MD3,5; Helle Zingenberg, MD3,6; Finn Stener J?rgensen, MD, DMSc3,7; Niels Vejlstrup, MD, PhD1,3; Kasper Iversen, MD, DMSc2,3; Henning Bundgaard, MD, DMSc1,3
doi : 10.1001/jama.2020.27205
JAMA. 2021;325(6):561-567
The prevalence and characteristics of bicuspid aortic valve (BAV) are mainly reported from selected cohorts. BAV is associated with aortopathy, but it is unclear if it represents a fetal developmental defect or is secondary to abnormal valve dynamics.
Iain Beehuat Tan, MBBS, PhD1,2; Clive Tan, MBBS, MPH3,4; Li Yang Hsu, MBBS, MPH2,4; Yock Young Dan, MBBS, PhD2,5; Andrew Aw, MDS6; Alex R. Cook, PhD4; Vernon J. Lee, MBBS, PhD2,4
doi : 10.1001/jama.2020.24071
JAMA. 2021;325(6):584-585
K. M. Venkat Narayan, MD, MSc1; James W. Curran, MD, MPH1; William H. Foege, MD, MPH1
doi : 10.1001/jama.2020.23479
JAMA. 2021;325(6):525-526
Stacie B. Dusetzina, PhD1,2
doi : 10.1001/jama.2020.25424
JAMA. 2021;325(6):527-528
Adam S. Lauring, MD, PhD1; Emma B. Hodcroft, PhD2
doi : 10.1001/jama.2020.27124
JAMA. 2021;325(6):529-531
Lawrence O. Gostin, JD1; Daniel A. Salmon, MPH, PhD2; Heidi J. Larson, PhD3
doi : 10.1001/jama.2020.26553
JAMA. 2021;325(6):532-533
Emily A. Largent, JD, PhD, RN1; Franklin G. Miller, PhD2
doi : 10.1001/jama.2020.27121
JAMA. 2021;325(6):534-535
Ambarish Pandey, MD, MSCS1; Dalane W. Kitzman, MD2
doi : 10.1001/jama.2020.26347
JAMA. 2021;325(6):537-539
Gregory Curfman, MD1
doi : 10.1001/jama.2021.0109
JAMA. 2021;325(6):540-541
Jeffrey N. Katz, MD, MSc1,2,3; Kaetlyn R. Arant, BA1; Richard F. Loeser, MD4
doi : 10.1001/jama.2020.22171
JAMA. 2021;325(6):568-578
Osteoarthritis (OA) is the most common joint disease, affecting an estimated more than 240 million people worldwide, including an estimated more than 32 million in the US. Osteoarthritis is the most frequent reason for activity limitation in adults. This Review focuses on hip and knee OA.
Gordon T. Moffat, MD1; Zhe Ren, BSc2; Andrew A. Simone, MD2
doi : 10.1001/jama.2020.16053
JAMA. 2021;325(6):579-580
Rita Rubin, MA
doi : 10.1001/jama.2020.23436
JAMA. 2021;325(6):517-519
Eve Escalante, MSW, LCSW1; Robyn L. Golden, MA, LCSW1; Diana J. Mason, PhD, RN2
doi : 10.1001/jama.2021.0100
JAMA. 2021;325(6):520-521
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.0241
JAMA. 2021;325(6):523
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.0074
JAMA. 2021;325(6):523
Jennifer Abbasi
doi : 10.1001/jama.2021.0493
JAMA. 2021;325(6):522
Jennifer Abbasi
doi : 10.1001/jama.2021.0227
JAMA. 2021;325(6):522
Jennifer Abbasi
doi : 10.1001/jama.2021.0495
JAMA. 2021;325(6):522
Rosalyn Buckland, PhD1; Michael K. Abernethy, MD2
doi : 10.1001/jama.2020.24787
JAMA. 2021;325(6):515-516
Scott Hendrik Van Hoeven, BSc1
doi : 10.1001/jama.2020.23816
JAMA. 2021;325(6):590
doi : 10.1001/jama.2020.17786
JAMA. 2021;325(6):591
Avani K. Patel, MD, MHA1; Alëna A. Balasanova, MD2
doi : 10.1001/jama.2020.2012
JAMA. 2021;325(6):596
Trevor J. Royce, MD, MS, MPH1
doi : 10.1001/jama.2020.23979
JAMA. 2021;325(6):585-586
Justin A. Grischkan, MD1; Ari B. Friedman, MD, PhD2; Amitabh Chandra, PhD3
doi : 10.1001/jama.2020.23988
JAMA. 2021;325(6):586
Lara C. Kovell, MD1; Colleen M. Harrington, MD1; Erin D. Michos, MD, MHS2
doi : 10.1001/jama.2020.23982
JAMA. 2021;325(6):586-587
Paul Muntner, PhD1; Shakia T. Hardy, PhD1
doi : 10.1001/jama.2020.23991
JAMA. 2021;325(6):587-588
Yue Li, MSc1; Junfeng Wang, PhD2
doi : 10.1001/jama.2020.24100
JAMA. 2021;325(6):588
Stephanie Eaneff, MSP1; Ziad Obermeyer, MD2; Atul J. Butte, MD, PhD3
doi : 10.1001/jama.2020.24103
JAMA. 2021;325(6):588-589
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟